Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma Ishikawa TWorld J Gastroenterol 2008[May]; 14 (18): 2797-801Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, including Japan. Although the development of imaging modalities has made the early diagnosis of HCC possible, surgically resectable cases are relatively uncommon because of hepatic function reserve and/or an advanced stage at presentation. Several modalities, such as transcatheter arterial chemoembolization, percutaneous ethanol injection, microwave coagulation therapy and radiofrequency ablation are reportedly useful in treating patients with non-resectable disease. However, unfortunately, many HCC patients have tumor recurrence. The overall prognosis of patients with HCC is very poor, and treatment of the advanced form is still problematic. In this article, we review the clinical efficacy and toxicity of enteric-coated tegafur/uracil in the treatment of patients with advanced non-resectable HCC.|Administration, Oral[MESH]|Antimetabolites, Antineoplastic/administration & dosage/adverse effects/*therapeutic use[MESH]|Carcinoma, Hepatocellular/*drug therapy[MESH]|Humans[MESH]|Liver Neoplasms/*drug therapy[MESH]|Tablets, Enteric-Coated[MESH]|Tegafur/administration & dosage/adverse effects/*therapeutic use[MESH]|Treatment Outcome[MESH]|Uracil/administration & dosage/adverse effects/*therapeutic use[MESH] |
